HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles G Eberhart Selected Research

Charles G Eberhart Research Topics

Disease

135Neoplasms (Cancer)
06/2022 - 03/2002
62Medulloblastoma
04/2022 - 08/2002
44Glioma (Gliomas)
06/2022 - 03/2005
33Glioblastoma (Glioblastoma Multiforme)
01/2021 - 10/2006
31Brain Neoplasms (Brain Tumor)
03/2022 - 08/2002
18Astrocytoma (Pilocytic Astrocytoma)
01/2019 - 07/2004
9Carcinogenesis
01/2016 - 09/2002
8Rhabdoid Tumor (Rhabdoid Tumors)
06/2022 - 02/2005
8Hypoxia (Hypoxemia)
04/2022 - 09/2010
8Carcinoma (Carcinomatosis)
08/2021 - 06/2006
7Uveal melanoma
06/2022 - 02/2012
6Retinoblastoma (Glioblastoma, Retinal)
06/2022 - 10/2016
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2022 - 10/2007
5Infections
06/2022 - 02/2005
5Neoplasm Metastasis (Metastasis)
05/2019 - 03/2013
4Cysts
12/2022 - 01/2013
4Melanoma (Melanoma, Malignant)
01/2022 - 08/2014
4Keratoconus
01/2020 - 05/2011
4Primitive Neuroectodermal Tumors (PNET)
01/2019 - 06/2003
4Meningioma (Meningiomas)
01/2019 - 10/2005
4Fuchs' Endothelial Dystrophy
01/2014 - 02/2010
4Alzheimer Disease (Alzheimer's Disease)
01/2014 - 09/2002
3Inflammation (Inflammations)
12/2022 - 11/2015
3Carcinoma in Situ
06/2022 - 12/2019
3Hemorrhage
03/2021 - 11/2002
3Retinal Detachment (Retinal Detachments)
01/2019 - 09/2012
3Disease Progression
01/2018 - 01/2014
3Diffuse Intrinsic Pontine Glioma
01/2017 - 06/2014
2Papilloma (Papillomatosis)
06/2022 - 12/2021
2Corneal Neovascularization
11/2020 - 01/2019
2Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2020 - 01/2019
2Pinealoma (Pineoblastoma)
05/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2003
20Messenger RNA (mRNA)IBA
01/2021 - 06/2003
19DNA (Deoxyribonucleic Acid)IBA
06/2022 - 02/2005
12Formaldehyde (Formol)FDA Link
06/2022 - 02/2011
12ParaffinIBA
06/2022 - 08/2010
12Biological ProductsIBA
01/2017 - 03/2004
11LigandsIBA
01/2019 - 03/2005
10RNA (Ribonucleic Acid)IBA
06/2022 - 05/2011
10MicroRNAs (MicroRNA)IBA
05/2019 - 04/2011
10Transcription Factors (Transcription Factor)IBA
01/2018 - 02/2008
9Retinaldehyde (Retinal)IBA
01/2021 - 07/2011
9Pharmaceutical PreparationsIBA
01/2021 - 01/2010
9Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2016 - 08/2006
8Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2022 - 09/2008
8Mechanistic Target of Rapamycin Complex 1IBA
04/2022 - 12/2013
8Biomarkers (Surrogate Marker)IBA
03/2021 - 12/2008
7Small Interfering RNA (siRNA)IBA
06/2022 - 03/2005
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021 - 09/2010
7Phosphotransferases (Kinase)IBA
01/2021 - 09/2008
7Mitogen-Activated Protein KinasesIBA
01/2021 - 01/2012
6Protons (Proton)IBA
03/2022 - 11/2013
6AmidesIBA
03/2022 - 11/2013
6Histones (Histone)IBA
05/2019 - 04/2009
6Oxygen (Dioxygen)IBA
01/2017 - 09/2010
5Temozolomide (Temodar)FDA LinkGeneric
06/2022 - 02/2013
5Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
03/2022 - 10/2013
5TOR Serine-Threonine KinasesIBA
01/2021 - 04/2005
5Telomerase (Telomerase Reverse Transcriptase)IBA
01/2019 - 06/2003
4Glutamine (L-Glutamine)FDA Link
03/2022 - 10/2019
4NucleotidesIBA
03/2022 - 10/2019
4CytokinesIBA
10/2021 - 09/2013
4Matrix Metalloproteinases (MMPs)IBA
01/2020 - 06/2006
4CateninsIBA
01/2019 - 12/2012
4ChromatinIBA
01/2018 - 12/2010
4AntigensIBA
01/2017 - 10/2003
4dipinacoline glutamateIBA
01/2017 - 09/2013
4MRK 003IBA
11/2016 - 02/2012
4Digoxin (Digitek)FDA LinkGeneric
11/2015 - 09/2010
4EnzymesIBA
11/2013 - 10/2007
4PolymersIBA
02/2013 - 11/2002
4cyclopamineIBA
12/2010 - 08/2002
3SteroidsIBA
12/2022 - 09/2012
3Glutathione (Reduced Glutathione)IBA
03/2022 - 01/2019
3Glucose (Dextrose)FDA LinkGeneric
03/2022 - 01/2017
3trametinibIBA
01/2021 - 01/2018
3Coloring Agents (Dyes)IBA
11/2017 - 08/2006
3OligonucleotidesIBA
01/2016 - 07/2007
3Lysine (L-Lysine)FDA Link
06/2014 - 04/2009
3Notch ReceptorsIBA
02/2012 - 11/2004
3beta CateninIBA
05/2004 - 09/2002
2Fluorescein (Funduscein)FDA LinkGeneric
10/2022 - 01/2021
2sapanisertibIBA
04/2022 - 03/2016
2LipidsIBA
04/2022 - 01/2022
2Glutamic Acid (Glutamate)FDA Link
03/2022 - 03/2016
2Keratins (Keratin)IBA
12/2021 - 01/2013
2Hypoxia-Inducible Factor 1IBA
03/2021 - 02/2016
2Hematoxylin (Haematoxylon)IBA
01/2021 - 01/2017
2Carboplatin (JM8)FDA LinkGeneric
01/2021 - 01/2019
2ProdrugsIBA
01/2021 - 10/2019
2Eosine Yellowish-(YS) (Eosin)IBA
01/2021 - 01/2017
2MitogensIBA
01/2020 - 02/2015
2MucinsIBA
01/2020 - 06/2018
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020 - 02/2008
2Insulin-Like PeptidesIBA
01/2020 - 03/2011

Therapy/Procedure

44Therapeutics
10/2022 - 07/2003
14Drug Therapy (Chemotherapy)
01/2021 - 07/2004
8Radiotherapy
01/2017 - 07/2004
4Immunotherapy
12/2021 - 10/2003